Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry

(2016) Simone Biscaglia et al.   PLATELETS

Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events

(2016) Marc P. Bonaca et al.   JAMA Cardiology

Early Medication Nonadherence After Acute Myocardial Infarction

(2015) Robin Mathews et al.  

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Long-Term Safety of Drug-Eluting and Bare-Metal Stents

(2015) Tullio Palmerini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Early Medication Nonadherence After Acute Myocardial Infarction

(2015) Robin Mathews et al.   Circulation-Cardiovascular Quality and Outcomes

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention

(2014) Akshay Bagai et al.   Circulation-Cardiovascular Interventions

Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial

(2014) Pascal Vranckx et al.   EUROPEAN HEART JOURNAL

Fixed-dose aspirin–clopidogrel combination enhances compliance to aspirin after acute coronary syndrome

(2014) Pierre Deharo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Switching Acute Coronary Syndrome Patients From Prasugrel to Clopidogrel

(2013) Mathieu Kerneis et al.   JACC-Cardiovascular Interventions

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

(2012) Marco Valgimigli et al.   CIRCULATION

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

(2011) R. C. Becker et al.   EUROPEAN HEART JOURNAL

Medication Adherence in Cardiovascular Disease

(2010) Steven Baroletti et al.   CIRCULATION

First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel

(2010) Udaya S. Tantry et al.   Circulation-Cardiovascular Genetics

Predictors and Impact of Bleeding Complications in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction

(2009) Steven V. Manoukian   AMERICAN JOURNAL OF CARDIOLOGY

Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

(2009) David A. Morrow et al.   CIRCULATION

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

(2008) Elliott M. Antman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY